Epidemiology of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 3, Issue 4, 1997, Pages 175-186

  Rajput, A H ^a   Birdi, S ^b  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b NONE

Author keywords

Epidemiology; Parkinson's disease

Indexed keywords

LEVODOPA;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 4; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC LINKAGE; HUMAN; INCIDENCE; NORTH AMERICA; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; UNITED STATES;

EID: 0031432993     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(97)00029-1     Document Type: Article

References (157)

1. 1. Rajput A.H., Rozdilsky B., Rajput Alex H. Accuracy of clinical diagnosis in Parkinsonism - a prospective study. Can. J. Neurol. Sci. 1991; 18: 275-278.
2. 2. Jellinger K. The pathology of Parkinsonism. In: Marsden C.D., Fahn S., eds. Movement Disorders 2. London: Butterworths and Co., 1987: 124-165.
3. 3. Duvoisin R., Golbe L.I. Toward a definition of Parkinson's disease. Neurology 1989; 39: 746.
4. 4. Ehringer H., Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytryamine) in human brain: their behaviour in extrapyramidal system diseases. Klinische Wochenschrift 1960; 38: 1236-1239.
5. 5. Vingerhoets F.J.G., Snow B.J., Schulzer M. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J. Nucl. Med. 1994; 35: 18-23.
6. 6. Vingerhoets F.J.G., Snow B.J., Tetrud J.W., Langston J.W., Schulzer M., Calne D.B. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann. Neurol. 1994; 36: 765-770.
7. 7. Schoenberg B.S., Anderson D.W., Haerer A.F. Prevalence of Parkinson's Disease in the Biracial Population of Copiah County. Mississippi. Neurology 1985; 35 (6): 841-845.
8. 8. Bharucha N.E., Bharucha E.P., Bharucha A.E., et al. Prevalence of Parkinson's disease in the Parsi Community of Bombay. India. Arch. Neurol. 1988; 45: 1321-1323.
9. 9. Morgante L., Rocca W.A., Di rosa A.E., et al. Prevalence of Parkinson's disease and other types of Parkinsonism: A door-to-door survey in three Sicilian municipalities. Neurology 1992; 42: 1901-1907.
10. 10. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study. Neurology 1992; 42: 1142-1146.
11. 11. Rajput A.H., Pahwa R., Pahwa P. Rajput Alex. Prognostic significance of the onset mode in Parkinsonism. Neurology 1993; 43: 829-830.
12. 12. de Rijk M.C., Rocca W.A., Anderson D.W., Melcon M.O., Breteler M.M.B., Maraganore D.M. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997; 48: 1277-1281.
13. 13. Jenkyn L.R., Reeves A.G., Warren T., et al. Neurological signs in senescence. Arch. Neurol. 1985; 42: 1154-1157.
14. 14. Weiner W.J., Nora L.M., Glantz R.H. Elderly inpatients: postural reflex impairment. Neurology 1984; 34: 945-947.
15. 15. Duncan G., Wilson J.A. Normal elderly have some signs of PS. Lancet 1989; 1392.
16. 16. Rajput A.H. Clinical features and nautral history of Parkinson's disease (special consideration of aging). In: Calne D.B., ed. Neurodegenerative Diseases. Philadelphia, PA: W.B. Saunders Company, 1994: 555-571.
17. 17. Moghal S., Rajput A.H., D'Arcy C., Rajput R. Prevalence of movement disorders in elderly community residents. Neuroepidemiology 1994; 13: 175-178.
18. 18. Moghal s., Rajput A.H., Meleth R., D'Arcy C., Rajput R. Prevalence of movement disorders in institutionalized elderly. Neuroepidemiobgy 1995; 14: 297-300.
19. 19. Kurland L.T., Darrell P.H., Darrell R.W. Epidemiologic and genetic characteristics of Parkinsonism: a review. International J. Neurol. 1961; 2 (1): 11-24.
20. 20. Marttila R.J. Epidemiology. In: Koller W.C., ed. Handbook of Parkinson's Disease. New York: Marcel Dekker Inc., 1987: 35-50.
21. 21. Rosati G., Graniere E., Pinna L., De Bastiani P., Pirisi A., Devoto M.C. The risk of Parkinson's disease in Mediterranean people. Neurology 1980; 32: 250-255.
22. 22. Hofman A., Collette H.J.A., Bartelds A.I.M. Incidence and risk factors of Parkinson's Disease in The Netherlands. Neuroepidemiology 1989; 8: 296-299.
23. 23. Harada H., Nishikawa S., Takahashi K. Epidemiology of Parkinson's disease in a Japanese city. Arch. Neurol. 1983; 40: 151-154.
24. 24. Kurland L.T., Molgaard C.A. The patient record in epidemiology. Scientific American 1981; 245 (4): 54-63.
25. 25. Kurland L.T. Epidemiology: incidence, geographic distribution and genetic considerations. In: Fields W.S., ed. Pathogenesis and Treatment of Parkinsonism. Springfield, IL: Thomas, 1958: 5-43.
26. 26. Nobrega F.T., Glattre E., Kurland L.T., Okazaki H. Comments on the epidemiology of Parkinsonism including prevalence and incidence statistics for Rochester, Minnesota, 1935-1966. In: Barbeau A., Brunette J.R., eds. Progress in Neurogenetics. Amsterdam: Excerpta Medica, 1967: 474-485.
27. 27. Rajput A.H., Offord K.P., Beard C.M., Kurland L.T. Epidemiology of Parkinsonism: incidence, classification, and mortality. Ann. Neurol. 1984; 16: 278-282.
28. 28. Lilienfeld D.E. An epidemiological overview of amyotrophic lateral sclerosis, Parkinson's disease, and dementia of the Alzheimer type. In: Calne D.B., ed. Neurodegenerative Diseases. Philadelphia, PA: W.B. Saunders Co., 1993: 399-425.
29. 29. Schoenberg B.S. Environmental risk factors for Parkinson's disease: the epidemiologic evidence. Can. J. Neurol. Sci. 1987; 14: 407-413.
30. 30. Mayeux R., Marder K., Cote L.J., et al. The frequency of idiopathic Parkinsons disease by age, ethnic group, and sex in Northern Manhattan, 1988-1993. Am. J. Epidemiol. 1995; 142: 820-827.
31. 31. Rajput A.H., Rozdilsky B., Hornykiewicz O., Shannak K., Lee T. Reversible drug-induced Parkinsonism. Clinicopathologic study of two cases. Arch. Neurol. 1982; 39: 644-646.
32. 32. Parkinson J. In: Critchley M., McMenemey W.H., Walshe F.M.R., Greenfield J.G., eds. A Bicentenary Volume of Papers Dealing with Parkinson's Disease. London: MacMillan 1955; .
33. 33. Duvoisin R.C. Yahr M.D. Encephalitis and Parkinsonism. Arch. Neurol. 1965; 12: 227-239.
34. 34. Krusz J.C., Koller W.C., Ziegler D.K. Historical Review: Abnormal movements associated with epidemic encephalitis lethargica. Mov. Disord. 1987; 3 (3): 137-141.
35. 35. Ayd F.J. A survey of drug-induced extrapyramidal reaction. JAMA 1961; 175: 1054-1060.
36. 36. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
37. 37. Shy G.M., Drager G.A. A neurological syndrome associated with orthostatic hypotension. Arch. Neurol. 1960; 2: 511-527.
38. 38. Adams R.D., van Bogaert L. Van der Eecken H. Striato-nigral degeneration. J. Neuropathol. Exp. Neurol. 1964; 23: 584-608.
39. 39. Steele J.C., Richardson J.C. Olszewski J. Progressive supra-nuclear palsy. Arch. Neurol. 1964; 10: 333-359.
40. 40. Goetz C.G. An early photographic case of probable supra-nuclear palsy. Mov. Disord. 1996; 11 (6): 617-618.
41. 41. Uitti R.J., Ahlskog J.E., Maraganore D.M., et al. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology 1993; 43: 1918-1926.
42. 42. Kurtzke J.F., Flaten T.P., Murphy F.M, Death rates from Parkinson's disease in Norway reflect increased survival. Neurology 1991; 41: 1665-1667.
43. 43. Lees A.J. When did Ray Kennedy's Parkinson's disease begin?. Mov. Disord. 1992; 7 (2): 110-116.
44. 44. Clarke C.E. Does Levodopa Therapy delay death in Parkinson's disease?. A review of the evidence. Mov. Disord. 1995; 10 (3): 250-256.
45. 45. Uitti R.J., Rajput A.H., Ahlskog J.E., et al. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology 1996; 46: 1551-1556.
46. 46. Vanacore N., Bonifati V., Bellatrecda A., Edito F., Meco G. Mortality Rates for Parkinson's disease and Parkinsonism in Italy (1969-1987). Neuroepidemiology 1992; 11: 65-73.
47. 47. Rybicki B.A., Johnson C.C, Uman J., gorell J.M. Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Mov. Disord. 1993; 8 (1): 87-92.
48. 48. de Pedro J., Rosenqvist U. Tracers for Paralysis Agitans in epidemiological research. Neuroepidemiology 1984; 3: 82-96.
49. 49. Menniti-Ippolito F., Spila-Alegiani S., Vanacore N., et al. Estimate of Parkinsonism prevalence through drug presciption histories in the Province of Rome. Italy. Acta Neurol. Scand. 1995; 92 (1): 49-54.
50. 50. Strickland D., Bertoni J.M., Pfeiffer R.F. Descriptive epidemiology of Parkinson's disease through proxy measures. Can. J. Neurol. Sci. 1996; 23: 279-284.
51. 51. Schoenberg B.S., Osuntokun B.O., Adejua A.O.G., et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988; 38: 645-646.
52. 52. Mutch W.J., Smith W.C., Scott R.F. A screening and alerting questionnaire for Parkinsonism. Neuroepidemiology 1991; 10: 150-156.
53. 53. Li S.C., Schoenberg B.S., Wang C.C., et al. A prevalence Survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch. Neurol. 1985; 42: 655-657.
54. 54. de Rijk M.C., Breteler M.M.B., Graveland G. A., et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam study. Neurology 1995; 45: 2143-2146.
55. 55. Diamond S.G., Markham C.H., Hoehn M.M., McDowell F.H., Muenter M.D. An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology 1990; 40: 763-766.
56. 56. Mutch W.J., Dingwall-Fordyce I., Downie A.W., Paterson J.G., Roy S.K. Parkinson's disease in a Scottish city. BMJ 1986; 292: 534-536.
57. 57. Svenson L.W. Regional disparities in the annual prevalence rates of Parkinson's disease in Canada. Neuroepidemiology 1991; 10: 205-210.
58. 58. Svenson L.W., Platt G.H., Woodhead S.E. Geographic variations in the prevalence rates of Parkinson's disease in Alberta. Can. J. Neurol. Sci. 1993; 20: 307-311.
59. 59. Lux W.E., Kurtzke J.F. Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis. Neurology 1987; 37: 467-471.
60. 60. Lilienfeld D.E., Sekkor D., Simpson S., et al. Parkinsonism death rates by race, sex and geography: a 1980's update. Neuroepidemiology 1990; 9: 243-247.
61. 61. Betemps E.J., Buncher C.R. Birthplace as a risk factor in motor neurone disease and Parkinson's disease. Int. J. Epidemiol. 1993; 22: 898-904.
62. 62. Rajput A.H., Stern W., Christ A., Laverty W. Etiology of Parkinson's disease: environmental factor(s) (Abstract). Neurology 1984; 34 (1): 207.
63. 63. Rajput A.H., Uitti R.J., Stern W., Laverty W. Early onset Parkinson's disease in Saskatchewan. Can. J. Neurol. Sci. 1986; 13: 312-316.
64. 64. Rajput A.H., Uitti R.J., Stern W., et al. Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease. Can. J. Neurol. Sci. 1987; 14: 414-418.
65. 65. Thiessen B., Rajput A.M., Laverty W., Desai H.B. Age, environments and the number of substantia nigra neurons. In: Streifler M.B., Korczyn A.D., Melamed E., Youdim M.B.H., eds. Advances in Neurology. New York: Raven Press, 1990: 201-206.
66. 66. Hertzman C., Wiens M., Bowering D., Snow B., Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Amer. J. Industrial Med. 1990; 17: 349-355.
67. 67. Koller W., Vetere-Overfield B., Gray C., et al. Environmental risk factors in Parkinson's disease. Neurology 1990; 40: 1218-1221.
68. 68. Tanner C.M., Chen B., Wang W., et al. Environmental factors in the etiology of Parkinson's disease. Can. J. Neurol. Sci. 1987; 14: 419-423.
69. 69. Hubble J.P., Cao T., Hassanein R.E.S., Neuberger J.S., Koller W.C. Risk factors for Parkinson's disease. Neurology 1993; 43: 1693-1697.
70. 70. Ludin S.M., Ludin H.P. Is Parkinson's disease of early onset a separate disease entity?. J. Neurol. 1989; 236: 203-207.
71. 71. Butterfield P.G., Valanis B.C., Spencer P.S., Lindeman C.A., Nutt J.G. Environmental antecedents of young-onset Parkinson's disease. Neurology 1993; 43: 1150-1158.
72. 72. Semchuk K.M., Love E.J., Lee R.G. Parkinson's disease and exposure to rural environmental factors: a population based case-control study. Can. J. Neurol. Sci. 1991; 18: 279-286.
73. 73. Seidler A., Hellenbrand W., Robra B.-P., Vieregge P. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996; 46: 1275-1284.
74. 74. Tanner C.M., Chen B., Wang W., Peng M. Environmental factors and Parkinson's disease: a case-control study in China. Neurology 1989; 39 (5): 660-664.
75. 75. Barbeau A., Roy M., Clouthier T., et al. Environmental and genetic factors in the etiology of Parkinson's disease. In: Yahr M.D., Bergmann K.J., eds. Advances in Neurology, Volume 45. New York: Raven Press, 1986: 299-306.
76. 76. Barbeau A., Roy M., Bernier G., Campanella G., Paris S. Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas. Can. J. Neurol. Sci. 1987; 14: 36-41.
77. 77. Semchuk K.M., Love E.J., Lee R.G. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992; 42: 1328-1335.
78. 78. Semchuk K.M., Love E.J., Lee R.G. Parkinson's disease: A test of the multifactorial etiologic hypothesis. Neurology 1993; 43: 1173-1180.
79. 79. Kessler I.I. Parkinson's disease: perspective of epidemiology and pathogenesis. Prev. Med. 1973; 2: 88-105.
80. 80. Alonso M.E., Otero E., D'Regules R., Figueroa H.H. Parkinson's disease: a genetic study. Can. J. Neurol. Sci. 1986; 13: 248-251.
81. 81. Roy M., Boyer L., Barbeau A. A prospective study of 50 cases of familial Parkinson's disease. Can. J. Neurol. Sci. 1983; 10: 37-42.
82. 82. Marder K., Tang M.-X., Mejia H., et al. Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 1996; 47: 155-160.
83. 83. Payami H., Larsen K., Bernard S., Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann. Neurol. 1994; 36: 659-661.
84. 84. Bonifati V., Fabrizio E., Vanacore N., De Mari M., Meco G. Familial Parkinson's disease: A clinical genetic analysis. Can. J. Neurol. Sci. 1995; 22: 272-279.
85. 85. Golbe L.I., Di lorio G., Sanges G., et al. Clinical genetic analysis of Parkinson's disease in the Contursi Kindred. Ann. Neurol. 1996; 40: 767-775.
86. 86. Duvoisin R.C. Is Parkinson's disease acquired or inherited?. Can. J. Neurol. Sci. 1984; 11: 151-155.
87. 87. Duvoisin R.C. Genetics of Parkinson's disease. In: Yahr M.D., Bergmann K.J., eds. Advances in Neurology. 45th edn. New York: Raven Press, 1986: 307-312.
88. 88. Maraganore D.M., Schaid D.J., Rocca W.A., Harding A.E. Anticipation in familial Parkinson's disease: A reanalysis of 13 United Kingdom kindreds. Neurology 1996; 47: 1512-1517.
89. 89. Armon C., Daube J.R., O'Brien P.C., Kurland L.T., Mulder D.W. When is an apparent excess of neurologic cases epidemiolgically significant?. Neurology 1991; 41: 1713-1718.
90. 90. Rajput A.H., Fenton M.E., George D., Rajput A., Wilson W., McCulloch L. Concordance of common movement disorders among familial cases. Mov. Disord. 1997; 12: 747-751.
91. 91. Bonifati V., Vanacore N., Meco G. Anticipation of onset age in familial Parkinson's disease. Neurology 1994; 44: 1978-1979.
92. 92. Waters C.H., Miller C. A. Autosomal dominant Lewy body Parkinsonism in a four-generation family. Ann. Neurol. 1994; 35: 59-64.
93. 93. Golbe L.I., Lazzarini A.M., Schwarz K.O., Mark M.H., Dickson D.W., Duvoisin R.C. Autosomal dominant Parkinsonism with benign course and typical Lewy-body pathology. Neurology 1993; 43: 2222-2227.
94. 94. Wszolek Z.K., Pfeiffer B., Fulgham J.R., et al. Western Nebraska family (family D) with autosomal dominant Parkinsonism. Neurology 1995; 45: 502-505.
95. 95. Markopoulou K., Wszolek Z.K., Pfeiffer R.F. A Greek-American kindred with autosomal dominant, levodopa-responsive Parkinsonism and anticipation. Ann. Neurol. 1995; 39 (3): 355-356.
96. 96. Maraganore D.M., Harding A.E., Marsden C.D. A clinical and genetic study of familial Parkinson's disease. Mov. Disord. 1991; 6 (3): 205-211.
97. 97. Payami H., Bernard S., Larsen K., Kaye J., Nutt J. Genetic anticipation in Parkinson's disease. Neurology 1995; 45: 135-138.
98. 98. Muenter M.D., Howard P.M., Okazaki H., et al. A familial Parkinson-dementia syndrome. Neurology 1986; 36 (suppl 1): 115.
99. 99. Rajput A.H. Environmental causation of Parkinson's disease. Arch. Neurol. 1993; 50: 651-652.
100. 100. Polymeropoulos M.H., Higgins J.J., Golbe L.I., et al. Mapping of a Gene for Parkinson's disease to chromosome 4q21-q23. Science 1996; 274: 1197-1199.
101. 101. Polymeropoulos M.H., Lavedan C., Leroy E., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047.
102. 102. Isozumi K., Kaplan J., Deng H.-X., et al. A large Saskatchewan kindred with Lewy body Parkinson disease: exclusion of 4q21-q23, Yp-pseudoautosomal region and dopamine beta-hydroxylase locus (Abstract). Can. J. Neurol. Sci. 1997; Suppl. 1: S23.
103. 103. Duvoisin R.C., Eldridge R., Williams A., Nutt J., Calne D. Twin study of Parkinson disease. Neurology 1981; 31: 77-80.
104. 104. Ward C.D., Duvoisin R.C., Ince S.E., Nutt J.D., Eldridge R., Calne D.B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983; 33: 815-824.
105. 105. Marttila R.J., Kaprio J., Koskenvuo M., Rinne U.K. Parkinson's disease in nationwide twin cohort. Neurology 1988; 38: 1217-1219.
106. 106. Tanner C.M., Ottman R., Ellenberg J.H., et al. Parkinson's disease (PD) concordance in elderly male monozygotic (MZ) and dizygotic (DZ) twins. Neurology 1997; (Abstract).
107. 107. Marsden C.D. Parkinson's disease in twins. J. Neurol. Neurosurg. Psychiatry 1987; 50: 105-106.
108. 108. Vieregge P., Schiffke K.A., Friedrich H.J., Muller B., Ludin H.P. Parkinson's disease in twins. Neurology 1992; 42: 1453-1461.
109. 109. Burn D.J., Mark M.H., Playford E.D., et al. Parkinson's disease in twins studied with 18F-dopa and positron emission tomograph. Neurology 1992; 42: 1894-1900.
110. 110. Holthoff V.A., Vieregge P., Kessler J., et al. Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits. Ann. Neurol. 1994; 36: 176-182.
111. 111. Menza M.A., Golbe L.I., Cody R.A., Forman N.E. Dopamine-related personality traits in Parkinson's disease. Neurology 1993; 43: 505-508.
112. 112. Rajput A.M., Offord K.P., Beard CM., Kurland L.T. A case control study of smoking habits, dementia and other illnesses in idiopathic Parkinson's disease. Neurology 1987; 37: 226-232.
113. 113. Hietanen M., Teravainen H. The effect of age of disease onset on neuropsychological performance in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1988; 51: 244-249.
114. 114. Brown R.G., Marsden C.D. How common is dementia in Parkinson's disease?. Lancet 1984; 2: 1262-1265.
115. 115. Mayeux R., Stern Y., Rosenstein R., et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch. Neurol. 1988; 45: 260-262.
116. 116. Martin W.E., Young W.I., Anderson V.E. Parkinson's disease: A genetic study. Brain 1973; 96 (III): 495-506.
117. 117. Rajput A.H., Rozdilsky B. Parkinsonism and dementia: effects of L-dopa. Lancet 1975; 1: 1084.
118. 118. Marttila R.J., Rinne U.K. Dementia in Parkinson disease. Acta Neurol. Scand. 1976; 54: 431-441.
119. 119. Rajput A.H. Prevalence of dementia in Parkinson's disease. In: Huber S.J., Cummings J.L., eds. Parkinson's Disease. Neurobehavioral Aspects. New York: Oxford University Press, 1992: 119-131.
120. 120. Mindham R.H.S., Ahmed S.W.A., Clough C.G. A controlled study of dementia in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1982; 45: 969-974.
121. 121. Mayeux R., Chen J., Mirabello E., et al. An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology 1990; 40: 1513-1517.
122. 122. Rajput A.H., Stern W., Laverty W.H. Chronic low dose therapy in Parkinson's disease: an argument for delaying levodopa therapy. Neurology 1984; 34 (8): 991-996.
123. 123. Uitti R.J., Rajput A.H., Offord K.P. Parkinsonism survival in the Levodopa Era. Neurology 1991; 41 (Suppl 1): 190.
124. 124. Marder K., Mirabello E., Chen J.J., et al. Death rates among demented and nondemented patients with Parkinson's disease. Ann. Neurol. 1990; 28 (2): 295.
125. 125. Mosewich R.K., Rajput A.H., Shuaib A., Rozdilsky B., Ang L. Pulmonary embolism: An under-recognized yet frequent cause of death in Parkinsonism. Mov. Disord. 1994; 9 (3): 350-352.
126. 126. Gorrell J.M., Johnson C.C., Rybicki B.A. Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality date, 1970 to 1990. Neurology 1994; 44: 1865-1868.
127. 127. Struck L.K., Rodnitzky R.L, Dobson J.K. Stroke and its modification in Parkinson's disease. Stroke 1990; 21: 1395-1399.
128. 128. Jansson B., Jankovic J. Low cancer rates among patients with Parkinson's disease. Ann. Neurol. 1995; 17: 505-509.
129. 129. Hammond E.C. Smoking in relation to the death of one million men and women. In: Epidemiologic Approaches to the Study of Cancer and Other Chronic Diseases. National Cancer Institute Monography No. 19. Washington: U.S. Government Printing Office, 1966: 127-204.
130. 130. Kahn H.A. The Dorn Study of smoking and mortality among US veterans: report on eight and one-half years of observation. In: Epidemiologic Approaches to the Study of Cancer and other Chronic Diseases. National Cancer Institute Monograph No. 19. Washington: U.S. Government Printing Office, 1966: 1-125.
131. 131. Nefzinger M.D., Quadfasel F. A., Karl V.C. A retrospective study of smoking and Parkinson's disease. Am. J. Epidemiol. 1968; 88: 149-158.
132. 132. Grandinetti A., Morens D.M., Reed D., MacEachern D. Prospective Study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am. J. Epidemiol. 1994; 139: 1129-1138.
133. 133. Morens D.M., Grandinetti A., Reed D., White L.R. Smoking-associated protection from Alzheimer's and Parkinson's disease. Lancet 1994; 343: 356-357.
134. 134. Baumann R.J., Jameson H.D., McKean H.E., Haack D.G., Weisberg L.M. Cigarette smoking and Parkinson's disease. A comparison of cases with matched neighbors. Neurology 1980; 30: 839-843.
135. 135. Godwin-Austen R.B., Lee P.N., Marmot M.G., Stern G.M. Smoking and Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1982; 45: 577-581.
136. 136. Morens D.M., Grandinetti A., Reed D., White L.R., Ross G.W. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue. Neurology 1995; 45: 1041-1051.
137. 137. Mayeux R., Tang M.X., Marder K., Cote L.J., Stern Y. Smoking and Parkinson's disease. Mov Disord 1994; 9 (2): 207-212.
138. 138. Calne D.B. Is idiopathic Parkinsonism the consequence of an event or a process. Neurology 1994; 44: 5-10.
139. 139. Haack D.G., Baumann R.J., McKean H.E., Jameson H.D., Turbeck J.A. Nicotine exposure and Parkinson's disease. Am. J. Epidemiol. 1981; 114: 191-200.
140. 140. Golbe L.I., Cody R.A., Duvoisin R.C. Smoking and Parkinson's disease. Search for a dose-response relationship. Arch. Neurol. 1986; 43: 774-778.
141. 141. Riggs J.E. The nonenvironmental basis for rising mortality from Parkinson's disease. Arch. Neurol. 1993; 50: 653-656.
142. 142. Behmand R. A., Harik S.I. Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. J. Neurochem. 1992; 58: 776-779.
143. 143. Hornabrook R.W., Nagurney J.T. Essential tremor in Papua. New Guinea. Brain 1976; 99: 659-672.
144. 144. Geraghty J.J., Jankovic J., Zetusky W.J. Association between essential tremor and Parkinson's disease. Ann. Neurol. 1985; 17: 329-333.
145. 145. Rajput A.M., Offord K.P., Beard C.M., Kurland L.T. Essential tremor in Rochester, Minnesota: a 45-year study. J. Neurol. Neurosurg. Psychiatry 1984; 47: 466-470.
146. 146. Marttila R.J., Rautakorpi I., Rinne U.K. The relation of essential tremor to Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1984; 47: 734-735.
147. 147. Cleeves L., Findley L.J., Koller W. Lack of association between essential tremor and Parkinson's disease. Ann. Neurol. 1988; 24: 23-26.
148. 148. Rajput A.H., Rozdilsky B., Ang L., Rajput A. Significance of Parkinsonian manifestations in essential tremor. Can. J. Neurol. Sci. 1993; 20: 114-117.
149. 149. Findley L.J., Gresty M.A., Halmagyi G.M. Tremor and cogwheel phenomena and clonus in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1981; 44: 534-546.
150. 150. Brooks D.J., Playford E.D., Ibanez V., et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study. Neurology 1992; 42: 1554-1560.
151. 151. Jankovic J., Beach J., Schwartz K., Contant C. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology 1995; 45: 645-648.
152. 152. Herskovits E., Blackwood W. Essential (familial, hereditary) tremor: a case report. J. Neurol. Neurosurg. Psychiatry 1969; 32: 509-511.
153. 153. Rajput A.H., Rozdilsky B., Ang L., Rajput A. Clinicopathological observations in essential tremor. Report of 6 cases. Neurology 1991; 41: 1422-1424.
154. 154. Gibb W.R.G., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1988; 51: 745-752.
155. 155. Gibb W.R. Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol. Appl. Neurobiol. 1986; 12: 223-234.
156. 156. Gibb W.R.G., Esiri M.M., Lees A.J. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1985; 110: 1131-1153.
157. 157. Wolf P.A., Feldman R.G., Saint-Hilaire M., et al. Precursors and natural history of Parkinson's disease: the Framingham Study. Neurology 1991; 41 (1): 371.